Respiratory System: Medicine

Department of Health written question – answered on 11th September 2017.

Alert me about debates like this

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary of State for Health

The information requested is shown in the table below.

Cost of respiratory medicines to the National Health Service, by primary and secondary care, in England from years 2012 to 2016

Primary Care Net Ingredient Cost (£)

Secondary Care Cost (£)

Total Cost (£)

2012

1,009,505,840

39,842,049

1,049,347,889

2013

1,020,038,047

39,938,913

1,059,976,960

2014

1,032,783,044

38,983,420

1,071,766,464

2015

1,044,951,211

38,600,943

1,083,552,154

2016

1,034,877,082

38,547,801

1,073,424,883

Source: Prescription Cost Analysis; 2016 QuintilesIMS: Hospital Pharmacy Audit Index

These figures do not include costs for treating respiratory infections or cancers, as the medicines required (antibiotics and chemotherapy) are used for other therapy areas and are not specific to respiratory disease. These costs are at list prices and discounts achieved by hospitals and community pharmacy have not been included.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.